Jean C Grégoire Selected Research

Stents

11/2021

Colchicine for Prevention of Atherothrombotic Events in Patients With Coronary Artery Disease: Review and Practical Approach for Clinicians.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean C Grégoire Research Topics

Disease

4	Acute Coronary Syndrome 11/2021 - 05/2010
4	Myocardial Infarction 11/2021 - 12/2019
3	Atherosclerotic Plaque (Atheroma) 11/2021 - 05/2010
3	Inflammation (Inflammations) 11/2021 - 08/2016
2	Atherosclerosis 11/2021 - 05/2010
2	Gout 01/2021 - 12/2019
2	Stroke (Strokes) 01/2021 - 11/2020
2	Pneumonia (Pneumonitis) 01/2021 - 12/2019
2	Pericarditis 01/2021 - 12/2019
2	Heart Arrest (Cardiac Arrest) 01/2021 - 11/2020
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 11/2020 - 01/2018
2	Hypertension (High Blood Pressure) 01/2017 - 01/2016
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021
1	Rupture 11/2021
1	Peripheral Arterial Disease 11/2021
1	Coronary Disease (Coronary Heart Disease) 01/2021
1	COVID-19 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 09/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2020
1	Diarrhea 12/2019
1	Xanthomatosis (Xanthoma) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Heart Failure 01/2018
1	Isolated Systolic Hypertension 01/2017
1	Frailty 01/2017
1	Stable Angina 01/2016
1	Hyperaldosteronism (Conn Syndrome) 01/2016
1	Hyperkalemia 01/2016
1	ST Elevation Myocardial Infarction 05/2013
1	Non-ST Elevated Myocardial Infarction 05/2013
1	Coronary Restenosis 03/2002

Drug/Important Bio-Agent (IBA)

5	Colchicine FDA LinkGeneric 11/2021 - 12/2019
2	LipidsIBA 11/2020 - 01/2016
2	LeukotrienesIBA 04/2017 - 05/2010
2	atreleutonIBA 04/2017 - 05/2010
2	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 04/2017 - 05/2010
1	InterleukinsIBA 11/2021
1	Spironolactone (Aldactone)FDA LinkGeneric 11/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2021
1	CytokinesIBA 11/2021
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2021
1	AndrogensIBA 09/2020
1	Apolipoproteins B (ApoB)IBA 01/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018
1	Lipoproteins (Lipoprotein)IBA 01/2018
1	LDL CholesterolIBA 01/2018
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2018
1	Angiotensin Receptor AntagonistsIBA 01/2018
1	Neprilysin (Neutral Endopeptidase)IBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Antihypertensive Agents (Antihypertensives)IBA 01/2017
1	dalcetrapibIBA 08/2016
1	CholesterolIBA 08/2016
1	Dietary PotassiumIBA 01/2016
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2016
1	P-SelectinIBA 05/2013
1	inclacumabIBA 05/2013
1	Lipoxygenase InhibitorsIBA 05/2010
1	AntioxidantsIBA 03/2002
1	Probucol (Lorelco)FDA Link 03/2002

Therapy/Procedure

5	Therapeutics 01/2021 - 01/2016
2	Percutaneous Coronary Intervention 11/2021 - 05/2013
1	Stents 11/2021
1	Secondary Prevention 11/2021
1	Time-to-Treatment 11/2020
1	Oral Administration 04/2017
1	Adrenalectomy 01/2016